Capital Asset Advisory Services LLC Sells 170 Shares of CVS Health Co. (NYSE:CVS) – Information Important Web

Capital Asset Advisory Services LLC downbound its function in shares of CVS Health Co. (NYSE:CVS – Free Report) by 1.7% in the prototypal quarter, according to the consort in its most past revealing with the Securities & Exchange Commission. The money owned 9,774 shares of the medicine operator’s hit after commerce 170 shares during the quarter. Capital Asset Advisory Services LLC’s holdings in CVS Health were worth $729,000 at the modify of the most past programme period.

A sort of another institutionalised investors and inclose assets also fresh prefabricated changes to their positions in CVS. Norges Bank bought a newborn wager in shares of CVS Health during the ordinal lodge worth $1,092,040,000. Capital International Investors accumulated its holdings in CVS Health by 47.4% in the ordinal quarter. Capital International Investors today owns 33,691,698 shares of the medicine operator’s hit valued at $2,660,298,000 after acquire an added 10,837,801 shares during the terminal quarter. Clearbridge Investments LLC accumulated its holdings in CVS Health by 306.6% in the ordinal quarter. Clearbridge Investments LLC today owns 3,046,216 shares of the medicine operator’s hit valued at $240,529,000 after acquire an added 2,297,100 shares during the terminal quarter. Junto Capital Management LP bought a newborn wager in CVS Health in the ordinal lodge valued at most $111,209,000. Finally, International Assets Investment Management LLC accumulated its holdings in CVS Health by 8,697.2% in the ordinal quarter. International Assets Investment Management LLC today owns 1,322,129 shares of the medicine operator’s hit valued at $104,395,000 after acquire an added 1,307,100 shares during the terminal quarter. Institutional investors possess 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of NYSE CVS unsealed at $59.09 on Friday. The hit has a 50 punctuation agitated cipher toll of $59.56 and a 200 punctuation agitated cipher toll of $70.19. CVS Health Co. has a 52 hebdomad baritone of $52.77 and a 52 hebdomad broad of $83.25. The consort has a debt-to-equity ratio of 0.78, a hurried ratio of 0.61 and a underway ratio of 0.81. The hit has a mart estimation of $74.18 billion, a PE ratio of 10.38, a price-to-earnings-growth ratio of 0.56 and a beta of 0.53.

CVS Health (NYSE:CVS – Get Free Report) terminal issued its quarterly earnings results on Wednesday, May 1st. The medicine cause reportable $1.31 EPS for the quarter, absent the consensus judge of $1.69 by ($0.38). CVS Health had a gain edge of 2.03% and a convey on justness of 13.53%. The consort had income of $88.44 1000000000 for the quarter, compared to shrink estimates of $89.33 billion. During the aforementioned punctuation terminal year, the consort posted $2.20 earnings per share. The business’s income for the lodge was up 3.7% on a year-over-year basis. Analysts prognosticate that CVS Health Co. module place 7.02 earnings per deal for the underway business year.

Analyst Upgrades and Downgrades

A sort of equities investigate analysts fresh commented on CVS shares. Bank of USA dropped their toll neutral on CVS Health from $95.00 to $77.00 and ordered a “buy” judgement for the consort in a inform on Thursday, May 2nd. SVB Leerink reissued a “market perform” judgement and issued a $60.00 direct toll (down from $87.00) on shares of CVS Health in a investigate state on Wednesday, May 1st. Truist Financial reissued a “buy” judgement and issued a $66.00 direct toll (down from $90.00) on shares of CVS Health in a investigate state on Thursday, May 2nd. author metropolis & Company attenuated their direct toll on CVS Health from $76.00 to $60.00 and ordered an “equal weight” judgement for the consort in a investigate state on Tuesday, May 7th. Finally, Leerink Partnrs revilement CVS Health from an “outperform” judgement to a “market perform” judgement in a investigate state on Wednesday, May 1st. Eleven equities investigate analysts hit rated the hit with a stop judgement and cardinal hit presented a acquire judgement to the company’s stock. According to accumulation from MarketBeat.com, the hit presently has an cipher judgement of “Moderate Buy” and a consensus toll direct of $75.05.

Get Our Latest Analysis on CVS Health

Insider Activity at CVS Health

In another CVS Health news, Director Edward J. Ludwig acquired 1,000 shares of the company’s hit in a dealings on Thursday, May 2nd. The shares were purchased at an cipher toll of $53.88 per share, for a amount dealings of $53,880.00. Following the termination of the purchase, the administrator today direct owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The dealings was unconcealed in a writing filed with the SEC, which is acquirable finished this link. Insiders possess 0.24% of the company’s stock.

About CVS Health

(Free Report)

CVS Health Corporation provides upbeat solutions in the United States. It operates finished Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits portion offers traditional, voluntary, and consumer-directed upbeat shelter products and attendant services.

Further Reading

Want to wager what another inclose assets are retentive CVS? Visit HoldingsChannel.com to intend the stylish 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).

Receive News & Ratings for CVS Health Daily – Enter your telecommunicate come beneath to obtain a apothegmatic regular unofficial of the stylish programme and analysts’ ratings for CVS Health and attendant companies with MarketBeat.com’s FREE regular telecommunicate newsletter.